My 50s were hard, she told the magazine
Next expected milestone Planned regulatory submission window Lillys stated Q1 2027 filing window opensJanuary 1, 2027 This tracks a stated filing window, not an FDA approval date
Learn more about the use of incretin hormones, the impact of weight management on psoriatic disease, metabolic and cardiovascular risk, as well as results from the TOGETHER Pso and TOGETHER PsA clinical trials
Choosing between these classes depends on clinical goals, comorbidities, genetic predisposition, tolerability, and cost
About Our Approach We combine personalized care with carefully chosen treatments to optimize your health and well-being
Doctors understand how it behaves, how to dose it and how to manage side effects